Therapeutic Apheresis and Dialysis

(The TQCC of Therapeutic Apheresis and Dialysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
COVID‐19 of dialysis patients in Japan: Current status and guidance on preventive measures47
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis28
Double filtration plasmapheresis: Review of current clinical applications26
Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan18
The scientific basis and future of lipoprotein apheresis15
Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study15
A COVID‐19 pandemic‐specific, structured care process for peritoneal dialysis patients facilitated by telemedicine: Therapy continuity, prevention, and complications management13
Super high‐flux hemodialysis provides comparable effectiveness with high‐volume postdilution online hemodiafiltration in removing protein‐bound and middle‐molecule uremic toxins:13
Application of plasmapheresis for Covid‐19 patients13
Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications13
Medium cut‐off dialyzers in a large population of hemodialysis patients in Colombia: COREXH registry13
Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically‐ill COVID‐19 patients12
Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?12
Two long‐term phase 3 studies of enarodustat (JTZ‐951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND‐Long an12
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta‐analysis of randomized controlled trials11
Severity of COVID‐19 in end‐stage kidney disease patients on chronic dialysis11
Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients11
Prolonged shedding of SARS‐CoV‐2 in COVID‐19 infected hemodialysis patients11
Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study11
Selective C‐reactive protein apheresis for Covid‐19 patients suffering from organ damage10
Renal replacement therapy for critically ill patients with COVID‐19‐associated acute kidney injury: A review of current knowledge10
Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients10
Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management9
Seroepidemiology of hepatitis E virus infection in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis9
Dynamic assessment of interleukin‐6 during hemodialysis and mortality in coronavirus disease‐199
Expanded hemodialysis as effective alternative to on‐line hemodiafiltration: A randomized mid‐term clinical trial9
A novel low‐density lipoprotein/fibrinogen apheresis method for chronic limb‐threatening ischemia in patients with poor options for revascularization: A multicenter, single‐arm clinical trial9
Impact of malnutrition on health‐related quality of life in patients on maintenance hemodialysis9
Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter ‐a device approved for the treatment of COVID‐19 patients8
Immunotherapy employing dendritic cell vaccination for patients with advanced or relapsed esophageal cancer8
Carbon footprint of a hemodialysis unit in Morocco8
l‐carnitine supplementation vs cycle ergometer exercise for physical activity and muscle status in hemodialysis patients: A randomized clinical trial8
Toxic myopathy and liver damage caused by concomitant therapy with remdesivir, atorvastatin, ezetimibe, and tacrolimus in a renal transplant patient with recently treated SARS‐CoV‐2 induced8
Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS8
Molidustat for the treatment of anemia in Japanese patients undergoing peritoneal dialysis: a single‐arm, open‐label, phase 3 study7
The German Lipoprotein Apheresis Registry—Summary of the ninth annual report7
Novel coronavirus disease in patients with end‐stage kidney disease7
The perspectives of dialysis patients about the Covid‐19 pandemic and differences between the modalities7
Humoral response to BNT162b2 mRNA COVID‐19 vaccine in peritoneal and hemodialysis patients: A comparative study7
Predicting a target exercise heart rate that reflects the anaerobic threshold in nonbeta‐blocked hemodialysis patients: The Karvonen and heart rate reserve formulas7
Cardiac geometry, function, and remodeling patterns in patients under maintenance hemodialysis and peritoneal dialysis treatment7
Standard renal replacement therapy combined with hemoadsorption in the treatment of critically ill septic patients7
Improved cognitive function after kidney transplantation compared to hemodialysis7
Antibody responses to the SARS‐CoV‐2 vaccines in hemodialysis patients: Is inactivated vaccine effective?7
The incidence of acute kidney injury and its association with mortality in patients diagnosed withCOVID‐19 followed up in intensive care unit7
Evaluation of psychopathological symptoms, death anxiety, coronavirus anxiety, suicide risk, and associated risk factors among hemodialysis patients in the COVID‐19 pandemic7
Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID‐19 infection: A retrospective observational study7
Prehemodialysis hyponatremia and extracellular water: Is it simply too much water?7
Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study6
Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients6
Therapeutic plasma exchange therapy support for critical COVID‐19: A case report6
Angiographic and clinical impact of novel low‐density lipoprotein apheresis for no‐option chronic limb‐threatening ischemia6
Fatigue and apathy in patients on chronic hemodialysis6
YouTube as a source of information on COVID‐19 and dialysis6
Unique case of macular edema following rituximab treatment for antibody‐mediated rejection in kidney transplant recipient6
Characteristics of pediatric continuous renal replacement therapies in hospitals with pediatric intensive care units in Japan6
Treatment of anemia associated with chronic kidney disease with the HIF prolyl hydroxylase inhibitor enarodustat: A review of the evidence6
The diagnostic and prognostic utility of serum cystatin C and angiopoietin 2 in patients with liver cirrhosis complicated by acute kidney injury5
Molidustat for anemia correction in Japanese patients undergoing hemodialysis: a single‐arm, phase 3 study5
Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders5
Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure—A retrospective analysis5
An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia5
Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: Analysis of a nationwide administrative database in Japan5
Primary hyperoxaluria type 1 in children: Clinical classification, renal replacement therapy, and outcome in a single centre experience5
Intradialytic isometric handgrip exercise does not cause hemodynamic instability: A randomized, cross‐over, pilot study5
Effect of anxiety on COVID‐19 infection in hemodialysis patients5
Increased 28‐day mortality due to fluid overload prior to continuous renal replacement in sepsis associated acute kidney injury5
Semaglutide, a newly available glucagon‐like peptide receptor agonist, shows remarkable favorable effects in hemodialysis patients with obesity and Type 2 diabetes5
HLA‐DR4 and DRB4: Potential risk alleles for COVID‐19 vaccination‐related ANCA‐associated vasculitis5
Effects of exercise therapy on the persistence of physical function, exercise habits, and self‐efficacy after cessation of exercise in patients undergoing hemodialysis: A nonrandomized control trial5
Pulmonary function, muscle strength, and quality of life have differed between chronic kidney disease patients and healthy individuals5
Therapeutic plasma exchange in the intensive care unit: Rationale, special considerations, and techniques for combined circuits5
Efficacy of medium cut‐off dialyzers and comparison with high‐flux dialyzers in patients on maintenance hemodialysis: A systematic review and meta‐analysis4
Early biochemical markers in the assessment of acute kidney injury in children after cardiac surgery4
Prognostic value of beta‐2 microglobulin on mortality in chronic kidney disease patients: A systematic review and meta‐analysis4
Beyond cholesterol—pleiotropic effects of lipoprotein apheresis4
Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis4
Granulocyte and monocyte adsorptive apheresis for pyoderma gangrenosum4
Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs4
Therapeutic plasma exchange in neurological diseases: Eleven years experience at a tertiary care center in Turkey4
Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder4
COVID‐19 vaccine hesitancy in renal transplant recipients4
Effects of one‐hour discussion on the choice of dialysis modality at the outpatient clinic: A retrospective cohort study using propensity score matching4
Midterm results of salvage surgery for autogenous dialysis access in aneurysmal arteriovenous fistulas4
Wilms' tumor 1 peptide‐loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia4
Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis4
IgA nephropathy following SARS‐CoV‐2 vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy4
Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single‐center phase I/II trial4
Baseline carotid intima‐media thickness is associated with cardiovascular morbidity and mortality in peritoneal dialysis patients4
Diastolic blood pressure is associated with brain atrophy in hemodialysis patients: A single center case–control study4
Sustained low‐efficiency dialysis with regional citrate anticoagulation for patients with liver impairment in intensive care unit: A single‐center experience4
Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy4
Dynamic and static balance functions in hemodialysis patients and non‐dialysis dependent CKD patients4
Clinical features, management, and outcome of hemodialysis patients with SARS‐CoV‐24
Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome: A Swedish retrospective observational study4
Lower serum albumin level is associated with increased risk of hospital admission and length of stay in hospital among incident hemodialysis patients by using overdispersed model4
Association between pill burden and interdialytic weight gain in patients with hemodialysis: A multi‐center cross‐sectional study4
Immunoadsorption to treat patients with severe post‐COVID syndrome4
Outcomes of early‐start peritoneal dialysis (PD) and the comparison with urgent‐start hemodialysis and conventional‐start PD3
Prevalence and outcome of abdominal wall hernia in patients with end‐stage renal disease on peritoneal dialysis3
Characteristics of hemodialysis patient with critical COVID‐193
Pregnancy in homozygous familial hypercholesterolemia—A case series3
Physical activity is associated with nutritional biomarkers in hemodialysis patients: A cross‐sectional study3
Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nes3
Peritonitis due to Alistipes finegoldii in a patient on peritoneal dialysis3
Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review3
Rapidly rising methemoglobinemia in a patient with severe COVID‐19 treated successfully with red cell exchange transfusion3
Comparison of functional patency rates between paclitaxel‐eluting versus plain balloon angioplasty in hemodialysis patients with central venous stenosis: An intra‐individual comparison study3
Vascular access in therapeutic apheresis: One size does not fit all3
Effect of sacubitril–valsartan on cardiac function in hemodialysis patients3
Elucidating the relationship between nutrition indices and coronary artery calcification in patients undergoing maintenance hemodialysis3
Impact of COVID‐19 lockdown on mood status: A comparison of hemodialysis and oncology patients3
Ocular manifestations in hemodialysis patients and short‐term changes in ophthalmologic findings3
A 1‐month‐old infant with Kawasaki disease on therapeutic plasma exchange3
When should polymyxin B‐immobilized polystyrene column be introduced to improve COVID‐19 prognosis?3
Sepsis associated acute kidney injury in pediatric intensive care unit3
Cryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature review3
The association between serum cystatin C and residual renal function in peritoneal dialysis patients3
Autoantibodies in COVID‐19, a possible role in the pathogenesis of the disease3
A phase 3, open‐label, single‐arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis‐stimulating agents3
Clinical study on the correlation between monocyte‐related ratios and calcification of the abdominal aorta in peritoneal dialysis patients3
Improving dialysis adequacy and quality of life in patients undergoing hemodialysis with twice a week range of motion exercise3
Factors influencing arteriovenous fistulas: A multicenter study3
A survey of cognitive function in peritoneal dialysis patients3
Simplified geriatric nutritional risk index for assessing nutritional status and stratifying mortality risk in patients receiving maintenance hemodialysis3
Association of bioimpedance‐derived 50‐kHz phase angle as marker of body composition with electrical parameters regarding the Cole‐Cole model3
The association between geriatric nutritional risk index variability and mortality in peritoneal dialysis patients3
Associations between liver function parameters and poor clinical outcomes in peritoneal dialysis patients3
Cardiac arrhythmia during early‐week and mid‐week dialysis in hemodialysis patients3
Angiogenic markers predict kidney injury and obstetric complications in women with preeclampsia and pregnancy‐related acute kidney injury3
Do biochemical parameters and intradialytic symptoms affectpost‐dialysisrecovery time? A prospective, descriptive study3
Median nerve swelling is an independent risk factor of carpal tunnel syndrome in chronic hemodialysis patients3
IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months3
Ultrafiltration volume by once‐weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis3
Clinical features and risk factors of catheter removal among 1062 episodes of peritoneal dialysis‐associated peritonitis: A multicenter 7‐year study3
Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study3
Holistic vision of the patient with chronic kidney disease in a universalistic healthcare system3
Peritoneal dialysis for refractory heart failure: A single‐center experience3
Effect of nutritional supplementation on mortality in peritoneal dialysis patients: A meta‐analysis3
Peritoneal sodium removal compared to glucose absorption in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis and automated peritoneal dialysis with and without a dayti3
Comparison of myoglobin clearance in three types of blood purification modalities3
Peritoneal dialysis‐related peritonitis caused by Paracoccus yeei3
Cardiovascular risk assessment and coronary artery calcification burden in asymptomatic patients in the initial years of hemodialysis3
Successful use of single‐pass albumin dialysis in the correction of severe hyperbilirubinemia in a case of acute hepatitis E3
Reimbursement for therapeutic apheresis devices and procedures for using the healthcare insurance system in Japan3
Durability of tunneled catheters in children is associated with catheter tip depth: A single‐center report2
Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients2
Short term‐efficacy and tolerability of Rheocarna, a novel direct hemoperfusion adsorptive column, for chronic limb‐threatening ischemia in dialysis patients: A single‐center case series2
Clinical performance comparison of two medium cut‐off dialyzers2
In vitro comparison of the endotoxin adsorption by blood purification devices2
Safety of a 24‐h‐or‐less break‐in period in elderly patients undergoing urgent‐start peritoneal dialysis: A multicenter retrospective cohort study2
Efficacy and safety of plasma diafiltration: Review of case reports and case series2
Hearing assessment in Egyptian children with chronic renal failure on regular hemodialysis and renal transplantation children2
Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID‐19 in a kidney transplant recipient with aHUS2
Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with COVID‐19 in clinical practice during the Omicron (BA.1 and BA.2) pandemic2
Expanded hemodialysis: Is anticoagulation of the dialysis circuit different from online hemodiafiltration and high‐flux hemodialysis?2
Impact of phosphate binders on medication dosing frequency, timing, and number of prescribed pills in hemodialysis patients2
During COVID‐19 stay at home even if you are a hemodialysis patient2
Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients2
Plasmapheresis for systemic vasculitis2
Infrequent use of nighttime dialysis for emergency admission due to worsening heart failure in patients on maintenance hemodialysis2
Cost of dialysis therapy by modality in Morocco: Cost‐minimization study comparing peritoneal dialysis to hemodialysis2
Dialysis and extracorporeal therapies for enhanced elimination of toxic ingestions and poisoning2
Effects of intradialytic exercise in combination with melatonin supplementation on functional capacity, postural balance, and quality of life in hemodialysis patients2
Magnesium intake by enteral formulation affects serum magnesium concentration in patients undergoing hemodialysis2
Long‐term outcomes of microwave ablation for secondary hyperparathyroidism in maintenance hemodialysis patients2
Blood filters in children with COVID‐19 and acute kidney injury: A review2
Comparison of plasma separation using centrifugation or filtration for MONET lipoprotein apheresis in patients with cardiovascular disease and severe dyslipidemia2
Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease2
Initiation of dialysis for kidney graft failure: A retrospective single‐center cohort study2
Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan2
The effect of nonpharmacologic interventions for muscle cramps and restless‐leg syndrome in hemodialysis patients: A meta‐analysis of randomized controlled trials2
Kidneys in SARS‐CoV‐2 era: A challenge of multiple faces2
Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study2
Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption‐type blood purification device for patients with chronic limb‐threatening ischemia2
Intradialytic BP variability is associated with cardiovascular mortality and hospitalization in HD patients2
Angled, long‐segment central venous occlusion in a hemodialysis patient recanalized by a novel “two‐step” strategy based on percutaneous superior vena cava puncture2
Changing the terminology from kidney replacement therapy to kidney support therapy2
Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator2
Favorable therapeutic efficacy of low‐density lipoprotein apheresis for nephrotic syndrome with impaired renal function2
Relation between carotid intimal medial thickness and left ventricular mass and left ventricular mass indices in maintenance hemodialysis patients2
Use of angiotensin converting enzyme inhibitors in patients receiving therapeutic plasma exchange with a centrifuge‐based apheresis system2
Clinical consequences of the suboptimal effect of messengerRNA‐basedSARS‐CoV‐2 vaccine in renal transplant recipients2
Range of serum transthyretin levels in hemodialysis patients at a high risk of 1‐year mortality: A retrospective cohort study2
How effective is rescue therapeutic plasma exchange in treatment of SARS‐Coronavirus‐2?2
Surgical outcomes of parathyroidectomy for secondary hyperparathyroidism resistant to calcimimetic treatment: A retrospective single‐center cohort study2
Association of serum potassium derangements with mortality among patients requiring continuous renal replacement therapy2
Impact of COVID‐19 on maintenance peritoneal dialysis patients and providers: A review2
Hemodialysis efficiency management from the viewpoint of blood removal pressure2
The significance of volume overload in the development of pulmonary arterial hypertension in continuous ambulatory peritoneal dialysis patients2
Effects of aromatherapy massage on the severity of restless legs syndrome in hemodialysis patients: A randomized clinical trial2
Combination therapy for COVID‐19 in hemodialysis patients: Pharmacological treatments and renal replacement therapy based on the severity2
Effects of demographic and clinical character on differences in self‐care behavior levels with arteriovenous fistula by hemodialysis patients: An ordinal logistic regression approach2
Sociodemographic features and outcomes of peritonitis episodes in children on peritoneal dialysis2
Peritoneal dialysis‐related peritonitis due to Corynebacterium striatum: An emerging multidrug‐resistant pathogen2
COVID‐19 in kidney transplant recipients; a DALMATIAN single‐center experience2
miR‐128‐3p inhibits high‐glucose‐induced peritoneal mesothelial cells fibrosis via PAK2/SyK/TGF‐β1 axis2
Clinical impact of a novel lipoprotein apheresis treatment on no‐option chronic limb‐threatening ischemia: Result from the REDUCTION VISCOSITY study2
Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study2
Factors that contribute to the cognitive impairment in elderly dialysis patients2
The prevalence and severity of mental health problems and sexual dysfunction in hemodialysis patients before and during the COVID‐19 pandemic2
Dialysis unit blood pressure two hours after hemodialysis is useful for predicting home blood pressure and ambulatory blood pressure in maintenance hemodialysis patients2
Peri‐dialytic hypoglycemia with hemodialysis and online post‐dilutional hemodiafiltration2
Risk factors for mortality in critically ill infants with acute kidney injury: A resource‐limited setting experience2
Clinical features and risk factors associated with mortality in critically ill children requiring continuous renal replacement therapy2
Milky effluent associated to lercanidipine in a peritoneal dialysis European patient2
Evaluation of switching treatment from high dose of darbepoetin to lower dose of roxadustat in Japanese hemodialysis patients2